Shock Wave Therapy Devices Market - By Technology (Focused {EMSG, EHSG, PSG}, Radial or Ballistic, Combined), Application (Orthopedic, Cardiology, Urology), Type (Portable, Fixed), End-use (Hospitals, Diagnostic Labs, ASC) - Global Forecast, 2024 - 2032

Shock Wave Therapy Devices Market - By Technology (Focused {EMSG, EHSG, PSG}, Radial or Ballistic, Combined), Application (Orthopedic, Cardiology, Urology), Type (Portable, Fixed), End-use (Hospitals, Diagnostic Labs, ASC) - Global Forecast, 2024 - 2032

Shock Wave Therapy Devices Market size is expected to grow at 4.9% CAGR during 2024-2032, driven by technological advancements, rising healthcare expenditure and investments in healthcare infrastructure along with rising regulatory approvals and reimbursement policies. Of late, the prevalence of musculoskeletal disorders and chronic conditions, such as tendinopathies, plantar fasciitis, and osteoarthritis is significantly increasing. According to the Institute for Health Metrics & Evaluation in 2023, cases of other musculoskeletal disorders are expected to surge by 115% from 2020 to 2050, reaching an estimated 1060 million prevalent cases by 2050.

With aging population and sedentary lifestyles becoming more prevalent globally, the incidence of these conditions is on the rise. Additionally, sports-related injuries are contributing to the growing burden of musculoskeletal ailments. Consequently, there is heightened demand for effective non-invasive treatment options like shock wave therapy devices to offer patients relief from pain and improve their quality of life. This increasing demand is underscoring the importance of innovative medical technologies in addressing the healthcare needs of individuals suffering from musculoskeletal disorders and chronic conditions, thereby inducing industry growth.

The shock wave therapy devices market is classified into technology, application, type, end-use and region.

Based on application, the industry size from the cardiology segment is set to attain 4.5% CAGR through 2032, as shock wave therapy has gained traction as an alternative treatment modality for refractory angina and peripheral arterial disease. The non-invasive nature of shock wave therapy makes it an attractive option for patients who are not suitable candidates for traditional revascularization procedures. As a result, cardiologists are incorporating shock wave therapy devices into their treatment protocols.

By type segmentation, the portable shock wave therapy devices market is poised to grow at 5.1% CAGR from 2024 to 2032. Portable devices offer the advantage of flexibility and convenience, allowing healthcare providers to administer shock wave therapy in various clinical settings, including outpatient clinics, sports medicine facilities, and rehabilitation centers. The portability of these devices is also enhancing the patient access to shock wave therapy treatments, contributing to the segment growth.

Asia Pacific shock wave therapy devices market is anticipated to grow at an unprecedented pace at 5.8% CAGR till 2032, driven by large population base, coupled with the increasing prevalence of musculoskeletal disorders and cardiovascular diseases. Moreover, the growing healthcare infrastructure and rising healthcare expenditure in countries, such as China, India, and Japan will further bolster market growth in the region.